People · Operator
Named in public records as an officer, director or promoter · active 2008–2022 · Pharma, Biotechnology, Other Travel
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Pyxis Oncology, Inc. | — | Pharma | Series D+ | $194.5M | $5.0B | 2021 |
| TScan Therapeutics, Inc. | — | Biotechnology | Series C | $123.3M | $3.3B | 2019 |
| Axcella Health Inc. | — | Biotechnology | Series C | $92.8M | $105.4M | 2022 |
| Taris Biomedical Inc | — | Biotechnology | Series B | $36.9M | $535.8M | 2009 |
| MicroCHIPS, Inc. | — | Biotechnology | Series B | $27.9M | $740.1M | 2009 |
| Protein Forest, Inc. | — | Biotechnology | Seed | $5.0M | $33.3M | 2008 |
| Crane Aviation Partners VII, LLC | — | Other Travel | Seed | $2.3M | $16.7M | 2019 |
Robert Crane at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Robert Crane on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Robert Langer | 2 | 36 |
| Michael Greeley | 2 | 15 |
| Christoph Westphal | 2 | 8 |
| Kevin Bitterman | 1 | 15 |
| Robert S Langer | 1 | 14 |
| Peter Barton Hutt | 1 | 14 |
| David Steinberg | 1 | 14 |
| Jack Nielsen | 1 | 13 |
| Terrance McGuire | 1 | 9 |
| Noubar Afeyan | 1 | 9 |
| Campbell Murray | 1 | 9 |
| Christopher O'Donnell | 1 | 8 |
| TERRANCE G. MCGUIRE | 1 | 7 |
| Geeta Vemuri | 1 | 7 |
| Ittai Harel | 1 | 6 |
| Lucio Iannone | 1 | 6 |
| Steve Kraus | 1 | 6 |
| Timothy Barberich | 1 | 6 |
| Diane Marcou | 1 | 5 |
| Andrew Hedin | 1 | 5 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.